GlobalData on MSN
Crystalys Therapeutics begins Phase III trials for gout treatment
The multi-centre, randomised, double-blind RUBY and TOPAZ studies are assessing the therapy’s performance against allopurinol ...
These Phase 3 clinical studies are designed to evaluate the safety and efficacy of dotinurad compared to an active control ...
Gout is the most common type of inflammatory arthritis. Eating foods like red meat, alcohol, and shellfish make the symptoms ...
Urica Therapeutics, a majority-owned subsidiary of Fortress, reported that Crystalys Therapeutics has dosed the first ...
Gout is a type of inflammatory arthritis. It occurs when your blood has a buildup of uric acid. This acid causes crystals to form in a joint, which leads to ...
Gout could be treated by an ancient gene that humans lost millions of years ago, suggests new research. A form of arthritis caused by crystals that build up in joints and cause swelling and pain, gout ...
GlobalData on MSN
Arthrosi gains $153m for development of gout therapy
US-based biotechnology company Arthrosi Therapeutics has completed a series E funding round, amassing $153m which is ...
Gout could be treated by an ancient gene that humans lost millions of years ago, suggests new research. A form of arthritis caused by crystals that build up in joints and cause swelling and pain, gout ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback